YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

Triangle firm slaps feds with lawsuit over delayed product launch Morrisville firm stunned by FDA setback, vows 'quick action ...

Liquidia Corporation ( NASDAQ: LQDA) said on Friday that the U.S. FDA has approved Yutrepia inhalation powder, a prostacyclin ...

The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...